A new study has
found tantalizing evidence that a highly concentrated form of a compound
found in red wine and dark chocolate might be able to slow the
progression of Alzheimer’s disease.
But it’s likely that it’s because the compound is tricking the body into acting as if it’s not eating at all.
Scott Turner, director of the
Memory Disorders Program at Georgetown University Medical Center who was
the study’s principal investigator, emphasized caution in interpreting
the results of the Phase 2 clinical trial, saying further research is
needed to determine whether the compound has a beneficial effect. He
also said people should not interpret the results to mean that they
should up their consumption of wine or begin taking over-the-counter
supplements.
But Turner said researchers were
excited to find that resveratrol produced a measurable effect on an
important biomarker of the disease’s advance in people who have mild or
moderate Alzheimer’s: the level of an abnormal protein known as beta
amyloid became stabilized in patients who consumed two grams of
resveratrol a day.
Normally, the level of beta
amyloid, which can be found in the bloodstream and in brain and spinal
fluids, declines and changes in composition as Alzheimer’s advances,
because the protein instead forms toxic beta amyloid plaques in the
brain.
But in the patients taking
resveratrol, the rate of decline in beta amyloid levels slowed. The
reason is not clear, Turner said. But he said the study - which was
published online Friday in the journal Neurology - lent further credence
to the idea that resveratrol stimulates enzymes that slow down
metabolism and age-related changes in the cell.
“So it’s really targeting what we
think are regulators of aging,” Turner said. “And of course aging is
the No. 1 risk factor for Alzheimer’s.”
More than 5 million people in the
United States have Alzheimer’s, which is the leading cause of dementia.
As demographics shift the country further to the gray, and the number
of Alzheimer’s patients is on a pace to nearly triple by 2050,
researchers are in the hunt for ways to slow or halt its onset.
Resveratrol is found in dark
chocolate, red wine, grape skins, peanuts and other plants. Plants
produce the compound when exposed to stressors. Exposed to cold or
infected with fungus, plants create more of the stuff.
Scientists believe the compound
stimulates the activity of enzymes known as sirtuins, which play an
important role in aging and metabolism. Sirtuins [sir-TOO-ins] have been
described as “guardians of the cell”; in particular, they appear to
enhance a cell’s ability to withstand stress and survive damage,
especially when the cell is deprived of food. Other studies have shown,
for example, that sirtuins are also activated by calorie restriction.
“Resveratrol is sort of a mimic
of caloric restriction, a pharmacological mimic. It’s a way of getting
the effects of caloric restriction without actually restricting
calories,” Turner said.
The one-year study involved 119
people recruited from 26 sites around the country. The youngest was 49
years old. All had a diagnosis of probable Alzheimer’s disease. Some
consumed as much as one gram of resveratrol twice a day - the equivalent
of 1,000 bottles of wine - of a form of the compound that is not
available on the market. Others were given a placebo.
Although some participants
experienced nausea and diarrhea, and others lost weight, while taking
the compound, the study found no signs of serious side effects. Those
who took the compound lost weight, while those on the placebo gained
weight.
Oddly, patients who took the
compound also experienced a decline in brain volume, as detected by MRI
scans — a finding that could be explained by a reduction in the
inflammation that often accompanies Alzheimer’s disease, Turner said. He
said the next step would be to move to a Phase 3 trial.
The study was funded by the National Institute on Aging and conducted with the Alzheimer’s Disease Cooperative Study.
Source: http://www.santafenewmexican.com/
Source: http://www.santafenewmexican.com/
No comments:
Post a Comment